Patterns of relapse and long-term outcome in patients treated with a curative intent for advanced Hodgkin lymphoma.
Karin NielsenMaja Vestmoe MaraldoAnne Kiil BerthelsenAnnika LoftPeter de Nully BrownIvan Richter VogeliusPeter Meidahl PetersenLena SpechtPublished in: Acta oncologica (Stockholm, Sweden) (2022)
Current treatment strategies for AHL provide excellent disease control. Neither initial bulk, high initial FDG-uptake, nor a residual CT-abnormality post-chemotherapy seem to indicate sites with a high risk of relapse.